About Us
FindExpertMD is an online big data resource to quickly find the top
published experts, both MDs and scientists, in specific diseases,
medical procedures, and
surgeries. It is designed by BioInfi, a developer of cutting edge
AI tools in the life science space that enable organizations to
achieve their scientific mission. BioInfi is led by Dr. Pankaj
Agarwal, a computational biologist with 23 years of experience
leading teams within the pharmaceutical industry to design and
build innovative applications to discover and develop new
medicines. Dr. Agarwal has published in top
journals on the use of literature to discover innovation, find targets,
repurpose medicines, and find experts. Dr. Agarwal serves as a
consultant to the Bill & Melinda Gates Foundation, and a
scientific advisor to BioAge and the PhRMA Foundation. He is a founder and a senior member of the
International Society for Computational Biology (ISCB).
Key Publications
- Can Literature Analysis Identify Innovation Drivers in Drug Discovery?
Agarwal P, Searls DB. Nat Rev Drug Discov. 2009
Nov;8(11):865-78. doi:
10.1038/nrd2973.
- Literature Mining in Support of Drug Discovery.
Agarwal P, Searls DB. Brief Bioinform. 2008
Nov;9(6):479-92. doi: 10.1093/bib/bbn035
- Electronic Health Records: Implications for Drug Discovery. Yao
L., Zhang Y., Li Y., Sanseau P., Agarwal P. Drug Discov Today. 2011 Jul;16(13-14):594-9.
doi: 10.1016/j.drudis.2011.05.009.
-
Could Advances in Representation Learning in Artificial Intelligence Provide the New Paradigm for Data Integration in Drug Discovery?
Vijayan V, Rouillard AD, Rajpal DK, Agarwal P. Expert Opin Drug
Discov. 2019 Mar;14(3):191-194. doi: 10.1080/17460441.2019.1573811. Epub 2019 Jan 30.
Acknowledgments
FindExpertMD is built from multiple open resources from
the National Library of Medicine (NLM) at the U.S. National Institutes
of Health (NIH). We gratefully
acknowledge the excellent resources from PubMed®, Medline®, Unified
Medical Language System®, ClinicalTrials.gov®, and MeSH®
(Courtesy of the U.S. National Library of Medicine). We also
acknowledge the disease treatment guidelines put together by
the
American Medical
Association,
National Institute for Health and Care Excellence (NICE) (UK),
National Comprehensive Cancer Network: NCCN (U.S., for cancer), and
the now archived
AHRQ
National Guideline Center (links from the
disease pages under this header are to the waybackmachine:internet archive). We have also utilized rare disease data
from
Orphanet and
the
Genetic
and Rare Diseases Information Center (GARD) from NCATS, NIH.
Contact
Please email us at
contact@bioinfi.com.